National Account Director jobs in United States
cer-icon
Apply on Employer Site
company-logo

KalVista Pharmaceuticals, Inc. · 1 day ago

National Account Director

KalVista Pharmaceuticals, Inc. is a global pharmaceutical company dedicated to delivering life-changing oral therapies for individuals affected by rare diseases. The National Account Director will be responsible for developing relationships with PBMs and managed care organizations to secure access for KalVista products, thereby contributing to the company's growth and transformation into a fully integrated biotechnology organization.

BiotechnologyDiabetesHealth Care

Responsibilities

Establish relationships with Pharmacy and Medical teams responsible for creating pharmacy and medical policies
Deliver Value proposition and Health Economic information to educate payers and the formulary committees
Create account plans to quickly maximize access and reimbursement with KalVista products
Collaborate with medical, advocacy and sales teams to remove access barriers for launch

Qualification

Managed care experienceNational Accounts experienceBiotech experienceExperience impacting policyStrategic thinkingExceptional communication skillsPresentation abilities

Required

Minimum 10 years field-based biotech/ pharmaceutical experience with at least 5 years of managed care experience
Bachelor's degree required
Exceptional communication skills and presentation abilities
Strategic thinking required
Experience impacting medical and pharmacy policy
Ability to travel greater than 50%
Self-motivated

Preferred

National Accounts experience preferred
Rare, Orphan, cell, gene, specialty experience preferred
Master's advanced degree preferred

Company

KalVista Pharmaceuticals, Inc.

twittertwittertwitter
company-logo
For nearly a decade, KalVista Pharmaceuticals has been focused on addressing the critical unmet needs of those living with hereditary angioedema (HAE).

Funding

Current Stage
Public Company
Total Funding
$821.8M
Key Investors
DRI Healthcare TrustRA Capital Management
2025-09-24Post Ipo Debt· $125M
2024-11-04Post Ipo Equity· $60M
2024-11-04Post Ipo Debt· $179M

Leadership Team

leader-logo
Benjamin Palleiko
Chief Executive Officer
linkedin
leader-logo
Brian Piekos
Chief Financial Officer
linkedin
Company data provided by crunchbase